Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Longevity Health Holdings, Inc. (XAGE : OTC)

• Company Description    Longevity Health Holdings Inc. operates as a bio-aesthetics company. The company utilizes Carmell Secretome to support skin and hair health. Longevity Health Holdings Inc., formerly known as Carmell Corporation, is based in Pittsburgh, Pennsylvania. Number of Employees: 15

• Price / Volume Information    Yesterday's Closing Price: $0.55 Daily Weekly Monthly 20 Day Moving Average: 5,735 shares Shares Outstanding: 1.78 (millions) Market Capitalization: $0.97 (millions) Beta: 0.34 52 Week High: $21.30 52 Week Low: $0.43 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -11.77% -14.09% 12 Week -78.55% -79.44% Year To Date -93.47% -94.29%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 2403 Sidney Street Suite 300 - Pittsburgh,PA 15203 USA ph: 919-313-9633 fax: - None http://www.carmellcorp.com

• General Corporate Information    Officers Rajiv Shukla - Chief Executive Officer and Chairman Bryan J. Cassaday - Chief Financial Officer Scott Frisch - Director Kathryn Gregory - Director Gilles Spenlehauer - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: CONSM PD-MISC DIS Sector: Consumer Discretionary CUSIP: 142922129 SIC: 2840 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/13/25 Share - Related Items Shares Outstanding: 1.78 Most Recent Split Date: 5.00 (0.03:1) Beta: 0.34 Market Capitalization: $0.97 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/13/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.93 EPS Growth vs. Year Ago Period: 67.53% vs. Previous Quarter: -2.63% Sales Growth vs. Year Ago Period: 4,100.00% vs. Previous Quarter: -1.18% ROE 09/30/25 - - 06/30/25 - - 03/31/25 - - ROA 09/30/25 - - 06/30/25 - -261.90 03/31/25 - -280.07 Current Ratio 09/30/25 - - 06/30/25 - 0.47 03/31/25 - 0.42 Quick Ratio 09/30/25 - - 06/30/25 - 0.30 03/31/25 - 0.21 Operating Margin 09/30/25 - - 06/30/25 - -682.58 03/31/25 - -1,534.94 Net Margin 09/30/25 - - 06/30/25 - -682.67 03/31/25 - -1,535.11 Pre-Tax Margin 09/30/25 - - 06/30/25 - -691.89 03/31/25 - -1,552.42 Book Value 09/30/25 - - 06/30/25 - -2.52 03/31/25 - -3.79 Inventory Turnover 09/30/25 - - 06/30/25 - 0.65 03/31/25 - 0.58 Debt-to-Equity 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Capital 09/30/25 - - 06/30/25 - - 03/31/25 - -

Powered by Zacks Investment Research ©